Ambu A/S

Company Profile

Ambu A/S had its IPO on under the ticker symbol AMBBY.

The company operates in the Healthcare sector and Medical Devices industry. Ambu A/S has a staff strength of 4,500 employees.

Stock update

Shares of Ambu A/S opened at $14.76 at the start of the last trading session i.e. 2023-03-21.

The stocks traded within a range of $14.76 - $14.76, and closed at $14.76.

This is a -1.27% slip from the previous day's closing price.

A total volume of 100 shares were traded at the close of the day’s session.

In the last one week, shares of Ambu A/S have slipped by -3.97%.

Ambu A/S's Key Ratios

Ambu A/S has a market cap of $3.98 billion, indicating a price to book ratio of 5.8523 and a price to sales ratio of 0.7638.

In the last 12-months Ambu A/S’s revenue was $4.54 billion with a gross profit of $2.55 billion and an EBITDA of $307 million. The EBITDA ratio measures Ambu A/S's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Ambu A/S’s operating margin was 3.3% while its return on assets stood at 1.41% with a return of equity of 2.36%.

In Q4, Ambu A/S’s quarterly earnings growth was a positive 12.5% while revenue growth was a positive 9.8%.

Ambu A/S’s PE and PEG Ratio

Forward PE

0

Trailing PE

291

PEG

Its diluted EPS in the last 12-months stands at $0.05 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Ambu A/S’s profitability.

Ambu A/S stock is trading at a EV to sales ratio of 0.8402 and a EV to EBITDA ratio of 7.5887. Its price to sales ratio in the trailing 12-months stood at 0.7638.

Ambu A/S stock pays annual dividends of $0 per share, indicating a yield of 0.32% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$7.01 billion

Total Liabilities

$996.00 million

Operating Cash Flow

$0

Capital Expenditure

$76 million

Dividend Payout Ratio

0%

Ambu A/S ended 2023 with $7.01 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $7.01 billion while shareholder equity stood at $4.12 billion.

Ambu A/S ended 2023 with $0 in deferred long-term liabilities, $996.00 million in other current liabilities, 129000000.00 in common stock, $3.78 billion in retained earnings and $1.56 billion in goodwill. Its cash balance stood at $125.00 million and cash and short-term investments were $125.00 million. The company’s total short-term debt was $82,000,000 while long-term debt stood at $1.38 billion.

Ambu A/S’s total current assets stands at $2.22 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $709.00 million compared to accounts payable of $509.00 million and inventory worth $1.21 billion.

In 2023, Ambu A/S's operating cash flow was $0 while its capital expenditure stood at $76 million.

Comparatively, Ambu A/S paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$14.76

52-Week High

$18.01

52-Week Low

$8.08

Analyst Target Price

$

Ambu A/S stock is currently trading at $14.76 per share. It touched a 52-week high of $18.01 and a 52-week low of $18.01. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $14.83 and 200-day moving average was $11.81 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.